News + Filings Transactions
|
Tammenoms Bakker Juliet
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/18/2023 | RxSight, Inc. | RXST | Sale | Common Stock | 14.7k | $29.07 | $425.9k | | 08/17/2023 |
| 08/17/2023 | RxSight, Inc. | RXST | Sale | Common Stock | 18.5k | $30.06 | $555.7k | | 08/17/2023 |
| 08/09/2023 | RxSight, Inc. | RXST | Other (disposition) | Common Stock | 497.2k | $0.00 | $0 | See footnote | 08/09/2023 |
| 08/09/2023 | RxSight, Inc. | RXST | Other (acquisition) | Common Stock | 33k | $0.00 | $0 | | 08/09/2023 |
| 06/14/2023 | RxSight, Inc. | RXST | Other (disposition) | Common Stock | 267.3k | $0.00 | $0 | See footnote | 06/14/2023 |
| 06/14/2023 | RxSight, Inc. | RXST | Other (acquisition) | Common Stock | 1k | $0.00 | $0 | | 06/14/2023 |
| 06/14/2023 | RxSight, Inc. | RXST | Other (acquisition) | Common Stock | 439 | $0.00 | $0 | See footnote | 06/14/2023 |
| 05/26/2023 | RxSight, Inc. | RXST | Other (disposition) | Common Stock | 497.2k | $0.00 | $0 | See footnote | 05/26/2023 |
| 05/26/2023 | RxSight, Inc. | RXST | Other (acquisition) | Common Stock | 33.1k | $0.00 | $0 | | 05/26/2023 |
| 06/02/2022 | RxSight, Inc. | RXST | Grant | | 10.3k | $0.00 | $0 | | 06/02/2022 |
| 08/03/2021 | RxSight, Inc. | RXST | Conversion | Series H Preferred Stock | 242k | $0.00 | $0 | See footnote | 08/03/2021 |
| 08/03/2021 | RxSight, Inc. | RXST | Exercise | Warrant (right to buy) | 36.3k | $12.40 | $450.1k | See footnote | 08/03/2021 |
| 08/03/2021 | RxSight, Inc. | RXST | Conversion | Series G Preferred Stock | 1.6M | $0.00 | $0 | See footnote | 08/03/2021 |
| 08/03/2021 | RxSight, Inc. | RXST | Purchase | Common Stock | 500k | $16.00 | $8M | See footnote | 08/03/2021 |
| 08/03/2021 | RxSight, Inc. | RXST | Purchase | Common Stock | 125k | $16.00 | $2M | See footnote | 08/03/2021 |
| 08/03/2021 | RxSight, Inc. | RXST | Conversion | Common Stock | 1.9M | $0.00 | $0 | See footnote | 08/03/2021 |
| 08/03/2021 | RxSight, Inc. | RXST | Purchase | Common Stock | 12.5k | $16.00 | $200k | | 08/03/2021 |
| 08/03/2021 | RxSight, Inc. | RXST | Exercise | Series H Preferred Stock | 36.3k | $0.00 | $0 | See footnote | 08/03/2021 |
| 08/03/2021 | RxSight, Inc. | RXST | Payment of Exercise | Series H Preferred Stock | 28.1k | $0.00 | $0 | See footnote | 08/03/2021 |
| 08/03/2021 | RxSight, Inc. | RXST | Conversion | Series H Preferred Stock | 8.2k | $0.00 | $0 | See footnote | 08/03/2021 |
| 07/30/2021 | RxSight, Inc. | RXST | Grant | | 5.9k | $0.00 | $0 | | 07/30/2021 |
| 05/17/2021 | Eargo, Inc. | EAR | Other (acquisition) | Common Stock | 3.5k | $0.00 | $0 | | 05/17/2021 |
| 05/17/2021 | Eargo, Inc. | EAR | Other (disposition) | Common Stock | 1000k | $0.00 | $0 | See Footnote | 05/17/2021 |
| 05/17/2021 | Eargo, Inc. | EAR | Other (acquisition) | Common Stock | 1.5k | $0.00 | $0 | See Footnote | 05/17/2021 |
| 04/14/2021 | Eargo, Inc. | EAR | Other (disposition) | Common Stock | 1000k | $0.00 | $0 | See Footnote | 04/14/2021 |
| 04/14/2021 | Eargo, Inc. | EAR | Other (acquisition) | Common Stock | 1.5k | $0.00 | $0 | See Footnote | 04/14/2021 |
| 04/14/2021 | Eargo, Inc. | EAR | Other (acquisition) | Common Stock | 3.5k | $0.00 | $0 | | 04/14/2021 |
| 10/20/2020 | Eargo, Inc. | EAR | Conversion | Common Stock | 3.7M | $0.00 | $0 | See Footnote | 10/20/2020 |
| 10/20/2020 | Eargo, Inc. | EAR | Purchase | Common Stock | 233.3k | $18.00 | $4.2M | See Footnote | 10/20/2020 |
| 10/20/2020 | Eargo, Inc. | EAR | Conversion | Series E Preferred Stock | 3.7M | $0.00 | $0 | See Footnote | 10/20/2020 |
| 10/15/2020 | Eargo, Inc. | EAR | Grant | Stock Option (Right to Buy) | 6.7k | $18.00 | $120k | | 10/15/2020 |
| 09/18/2020 | Axonics, Inc. | AXNX | Sale | Common Stock | 9.2k | $42.67 | $391.1k | | 09/18/2020 |
| 08/24/2020 | Axonics, Inc. | AXNX | Grant | Common Stock | 3.5k | $0.00 | $0 | | 08/24/2020 |
| 08/14/2020 | Axonics, Inc. | AXNX | Sale | Common Stock | 2.4k | $43.22 | $103.4k | | 08/14/2020 |
| 08/10/2020 | Axonics, Inc. | AXNX | Other (disposition) | Common Stock | 978k | $0.00 | $0 | By Longitude Venture Partners III, L.P. | 08/10/2020 |
|
|